The document is a regulatory filing submitted to the BSE and NSE, notifying them that the audio recording of a post-results conference call has been made available.
The event was a Post Results Conference Call held on 4th August, 2026.
The stated purpose of the event was to discuss the company's quarterly results, as it is labeled a 'Post Results' call.
The audio recording of the call has been hosted on the company's official website and is accessible at: https://alembicpharmaceuticals.com/quarterly-results.
The filing is signed by Manisha Saraf, Company Secretary.
The document references a prior intimation about this event that was sent to the exchanges on 27th July, 2026.
Additional Notes Section
The document itself is a compliance letter submitted to the stock exchanges (BSE and NSE).
No financial data, guidance, or strategic updates were disclosed in this specific announcement. This is purely a procedural update regarding the availability of a prior event's recording.
The document does not specify if a presentation deck or transcript was also made available, only the audio recording.
The document does not contain any explicit compliance language stating that no Unpublished Price Sensitive Information (UPSI) was shared during the call.
